Stay updated on Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.

Latest updates to the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page
- Check5 days agoChange DetectedThe page history now shows a new site revision (v3.6.3) replacing the previous revision (v3.6.2). This indicates an updated ClinicalTrials.gov interface or backend release rather than changes to study data or content.SummaryDifference0.1%

- Check12 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, replacing the previous revision (v3.6.0). This reflects an update to the page's revision metadata and the versioning of the ClinicalTrials.gov history interface rather than a substantive change to study content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe history now records that the study is no longer recruiting participants. It also adds a new release revision v3.6.0 and removes the prior revision v3.5.5 from the history.SummaryDifference0.5%

- Check33 days agoChange DetectedThe record history was updated to replace the previous revision (v3.5.4) with a newer revision (v3.5.5), reflecting a version update in the page history.SummaryDifference0.1%

- Check55 days agoChange DetectedThe Record History page version was updated from v3.5.3 to v3.5.4, representing a new published revision.SummaryDifference0.1%

- Check69 days agoChange DetectedThe Record History page now shows revision v3.5.3, replacing the previous v3.5.2. It reflects a small update to the page's revision history rather than changes to the study content.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.